The Kevin Trudeau Show: 2-23-10
Today, Kevin risks his own freedom to give YOU the truth! Find out why the FTC is going after him and not McDonald’s or Big Pharma and why the first amendment apparently doesn’t apply to him.
Plus, get the headlines you won’t hear from the mainstream media:
Big Pharma Researcher Admits to Faking Research!
GlaxoSmithKline Hid Evidence of Avandia Harm
Pfizer Found Guilty of Criminal Fraud
Hospital Infections Have Killed Over 48,000 People
Acne Drug has Side Effect of Death
Take Trudeau on the Go! Click here to download this show to your iPod, mp3 player, or PC through iTunes!
Click below to hear The Kevin Trudeau Show RIGHT NOW!!!
More People Dying Of Infections Acquired At Hospitals
February 23, 2010
Reuters
Pneumonia and blood-borne infections caught in hospital killed 48,000 patients and cost $8.1 billion in 2006, according to a report released on Monday.
The study is one of the first to put a price tag on the widespread problem, which is worsening and which some experts say is adding to the growing cost of healthcare in the United States.
“In many cases, these conditions could have been avoided with better infection control in hospitals,” said Ramanan Laxminarayan of Resources for the Future, a think tank that sponsored the study.
Sepsis — a blood infection — killed 20 percent of patients who developed it after surgery, Laxminarayan and colleagues reported in the Archives of Internal Medicine.
They studied hospital discharge records from 69 million patients at hospitals in 40 U.S. states between 1998 and 2006, looking for two diagnoses — hospital-acquired pneumonia and sepsis.
Patients who developed sepsis after surgery had to stay in the hospital on average nearly 11 days extra, at a cost of $32,900 per patient, they found. And just under 20 percent of them died.
Pneumonia patients stayed an extra 14 days after surgery, at a cost of $46,400 and more than 11 percent of them died, the researchers found.
“That’s the tragedy of such cases,” said Anup Malani of the University of Chicago, who worked on the study.
“In some cases, relatively healthy people check into the hospital for routine surgery. They develop sepsis because of a lapse in infection control and they can die.”
The researchers said that 1.7 million healthcare-associated infections are diagnosed every year.
Many are due to drug-resistant bacteria, such as methicillin resistant Staphylococcus aureus or MRSA, which cost more to treat because only a few drugs can work against them. These infections can also be caught outside hospitals and some studies show that such community-acquired infections are also on the rise.
One estimate from Pfizer Inc suggested that treating MRSA alone cost $4 billion a year.
Measures to prevent infection are simple and include careful handwashing, hygiene and screening patients when they check in. However, these measures are difficult to enforce, many studies have found.
Click here for the full report.
CDC Says Swine Flu Killed 17,000 in U.S.
February 15th, 2010
infowars.com
By Neka Sehgal
According to new estimates by the U.S. heath authorities, the dreaded H1N1 pandemic, which has shown sustained human-to-human transmission since its outbreak in April may have killed close to 17,120 people.
The new report released Friday by the Centers for Disease Control and Prevention (CDC) provides an assessment of infections, hospitalizations and deaths from H1N1 since its emergence in April until mid January.
It estimates 57 million citizens have been infected by the virus since the outbreak and the total could be as high as 84 million.
Younger generation hit hard by virus
Unlike the regular flu that strikes the elderly more viciously, the report shows the circulating virus targeted the younger generation, comprising kids, teens and adults.
Click here for the full report
Disinfectants Helping Germs Evolve into Superbugs
January 13, 2010
Natural News
By S. L. Baker
The opportunistic bacterium Pseudomonas aeruginosa is increasingly recognized as a cause of severe nosocomial infections — those are infections people contract as a result of treatment in a hospital or other medical center. In fact, a Pseudomonas aeruginosa infection can be life-threatening, especially if someone is immunocompromised.
The germ also causes chronic infections in cystic fibrosis patients. So it’s no surprise that disinfectants are widely sprayed, sloshed and wiped over surfaces in medical settings to supposedly protect patients. But now comes evidence the very act of relying on disinfectants to prevent Pseudomonas aeruginosa infections could be turning the already dangerous germ into a superbug that’s resistant to antibiotics as well as the disinfectant itself.
Germs adapt to survive
For a study just published in the January issue of the journal Microbiology, researchers from the National University of Ireland in Galway took laboratory cultures of Pseudomonas aeruginosa and added increasing amounts of disinfectant to the bacteria. They found this caused the germs to adapt over time so they could survive the disinfectant.
But something else also happened when the bacteria were exposed to the disinfectant. Remarkably, the germs became resistant to ciprofloxacin, a strong antibiotic widely-prescribed to fight Pseudomonas aeruginosa. And the germs became resistant to the drug even though they weren’t exposed to it.
How could this be possible? The scientists discovered that when exposed to the disinfectant, the bacteria adapted to more efficiently pump out antimicrobial agents (both the disinfectant and antibiotics) from the germ’s cells. The researchers also found the bacteria’s adaptation resulted in a DNA mutation that allowed the Pseudomonas aeruginosa microbes to specifically become immune to ciprofloxacin-type antibiotics.
Dr. Gerard Fleming, who headed the research team, warned in a media statement that the study results could mean “… residue from incorrectly diluted disinfectants left on hospital surfaces could promote the growth of antibiotic-resistant bacteria. What is more worrying is that bacteria seem to be able to adapt to resist antibiotics without even being exposed to them.”
Obviously, if disinfectants used to kill bacteria on surfaces to prevent their spread are actually making the germs stronger so they survive and go on to infect patients — and if antibiotics used to treat these infections are no longer effective — the results could be a serious threat to hospitalized patients. Dr. Fleming added that it is important for scientists to zero in on environmental factors that might promote antibiotic resistance, thereby creating superbugs.
“We need to investigate the effects of using more than one type of disinfectant on promoting antibiotic-resistant strains. This will increase the effectiveness of both our first and second lines of defense against hospital-acquired infections,” he stated.
France Cancels Order for Flu Vaccine
January 06, 2010
Reuters
By Anna Willard
France has canceled over half the flu vaccines it ordered to combat the H1N1 flu virus, Health Minister Roselyne Bachelot said on Monday, in an effort to head off criticism after reserving too many shots.
France ordered the vaccinations from Sanofi-Pasteur, a unit of Sanofi-Aventis, GlaxoSmithKline, Novartis and Baxter International.
The government estimated 94 million individual shots were needed, thinking that everyone would need two jabs for immunity against the illness.
Doctors now say a single vaccination is sufficient, meaning that France, with a population of some 65 million has a massive oversupply and is already trying to sell on some of the surplus shots it has received.
“I have canceled 50 million doses,” Bachelot said on TF1 television.
“These orders had not been paid for or delivered so they are canceled,” she added.
The Health Ministry said it had originally bought the 94 vaccines at a cost of 869 million euros. Bachelot said the canceled order would save more than 350 million euros.
Opposition politicians have criticized the government, saying it has wasted money and helped drugs companies. Socialist Party spokesman Benoit Hamon said large pharmaceutical firms were “the big winners in this affair.”
A Sanofi-Aventis spokesman said on Monday that the company and the government had started a review of a contract for 28 million vaccine doses before the Christmas holidays.
About half of the doses had been delivered he said but it was premature to comment on the implication of the canceled order for the company. Some five million people in France have so far been vaccinated against H1N1, health officials say.
The flu virus has killed an estimated 198 people on mainland France, according to data released on December 29, but doctors have said new infections have fallen sharply in recent weeks.
Half of ICU Patients Suffer From Infections
December 2, 2009
ABC News
By Maggie Fox
Half of all patients in intensive care units around the world have infections, and more than 70 percent are being given antibiotics — a trend that could help more drug-resistant superbugs emerge, researchers reported on Tuesday.
Patients who had infections were more likely to die, especially of bloodborne infections known as sepsis, the survey of more than 13,000 patients found. They also spent more time in the ICU at greater expense to hospitals and patients.
But one of the biggest concerns was the widespread use of antibiotics in patients who were not infected — a practice that has been shown to lead to antibiotic resistance, when germs defy common drugs.
“Importantly, the incidence of sepsis is increasing, as is the number of consequent infection-related deaths,” Dr. Jean-Louis Vincent of Erasme University Hospital in Brussels, Belgium and colleagues wrote in the Journal of the American Medical Association.
For the study, Vincent’s team surveyed 13,796 adults in 1,300 intensive care units in 75 countries on one day — May 8, 2007.
The analysis took some time and revealed that 51 percent of the patients had infections and 71 percent were receiving antibiotics, either as treatment or to prevent infection.
In 64 percent of cases, the lungs were infected, and infections of the abdomen and bloodstream were also common.
The most common bacteria was Staphylococcus aureus, but E. coli and a family of bacteria called Pseudomonas were also common.
“Infection and related sepsis are the leading cause of death in noncardiac ICUs, with mortality rates that reach 60 percent and account for approximately 40 percent of total ICU expenditures,”
MRSA Bacteria Popping Up in American Hospitals
November 25, 2009
U.S. News
By Jennifer Thomas
Strains of antibiotic-resistant infections normally found in the community are increasingly showing up among hospital outpatients, raising the risk that inpatients could become infected, new research says.
From 1999 to 2006, researchers found a sevenfold increase in the incidence of outpatients with methicillin-resistant Staphylococcus aureus (MRSA) infections. Outpatients include people treated in emergency departments or surgical centers but not admitted, or at doctors’ offices associated with hospitals.
This poses a risk to inpatients because many resources are used by both sets of patients. These include surgical centers and the doctors themselves, who often treat patients both inside and outside of hospitals.
“What this is suggesting is that outpatients are a significant source of MRSA, especially community-associated MRSA strains,” said the study’s lead author, Eili Klein, a doctoral candidate at Princeton University and a researcher at Resources for the Future, a Washington, D.C.-based think tank. “This suggests the need for incentives to make sure hospitals are not only taking steps to prevent hospital-associated strains from spreading among inpatients, but preventing the spread of community-associated strains through shared resources.”
The study is published in the December issue of Emerging Infectious Diseases.
MRSA, which burst into the public consciousness in the 1990s, is named for its resistance to methicillin and other antibiotics. There are several strains, including those that emerged in hospitals, called “hospital associated,” and those that emerged outside hospitals and tend to spread in schools and gyms, called “community associated.”
While both types can cause serious, life-threatening illness, hospital-acquired strains are generally more virulent. The bacteria can get into wounds, causing deadly blood or lung infections. About 20,000 people in the United States die each year from the MRSA infections, according to background information in the study.
Community-associated strains have also caused some deaths in otherwise healthy people, including several children who were killed by MRSA infections in the late 1990s. Typically, however, community-associated strains cause skin or other soft tissue infections that are treatable with newer antibiotics.
Swine Flu Escaped From Lab
November 25, 2009
Bloomberg
By Simeon Bennett
Adrian Gibbs, the virologist who said in May that swine flu may have escaped from a laboratory, published his findings today, renewing discussion about the origins of the pandemic virus.
The new H1N1 strain, which was discovered in Mexico and the U.S. in April, may be the product of three strains from three continents that swapped genes in a lab or a vaccine-making plant, Gibbs, and fellow Australian scientists wrote in Virology Journal. The authors analyzed the genetic makeup of the virus and found its origin could be more simply explained by human involvement than a coincidence of nature.
Their study, published in a free, online journal reviewed by other scientists, follows debate among researchers six months ago, when Gibbs asked the World Health Organization to consider the hypothesis. After reviewing Gibbs’ initial three-page paper, WHO and other organizations concluded the pandemic strain was a naturally occurring virus and not laboratory-derived.
“It is important that the source of the new virus be found if we wish to avoid future pandemics rather than just trying to minimize the consequences after they have emerged,” Gibbs and colleagues John Armstrong and Jean Downie said in today’s eight- page study.
Gibbs and Armstrong are on the emeritus faculty at the Australian National University in Canberra and Downie is affiliated with the Centre for Infectious Diseases and Microbiology Laboratory Services at Sydney’s Westmead Hospital, according to the study.
While the exact source of the new H1N1 strain is a mystery, their research has “raised many new questions,” they said. The authors compared the genetic blueprints of flu strains stored in the free database Genbank and found the pandemic virus’s nearest ancestors circulate in pigs.
WHO Looking Into Drug Resistant Swine Flu
November 25, 2009
Yahoo News
By Stephanie Nebehay
The World Health Organization is looking into reports in Britain and the United States that the H1N1 flu may have developed resistance to Tamiflu in people with severely suppressed immune systems, a spokesman said Tuesday.
Britain’s Health Protection Agency (HPA) said five cases have been confirmed in Wales of patients infected with H1N1 resistant to oseltamivir — the generic name of Roche and Gilead Sciences Inc’s antiviral drug Tamiflu.
The patients had serious conditions that suppressed their immune systems, which can give the virus a better than usual opportunity to develop resistance, the HPA said. It said the drug-resistant strain had probably spread person to person.
“We have seen the reports, we need to look into them,” WHO spokesman Thomas Abraham said in Geneva.
The U.S. Centers for Disease Control and Prevention last week also reported four cases of H1N1 resistant to Tamiflu at Duke University Hospital in North Carolina. All were said to be very ill with underlying severely compromised immune systems and multiple other complex medical conditions.
The WHO spokesman said both the reports involved Tamiflu resistance in people with severely compromised immune systems.
“We’ll see if we need to put any additional measures in place to protect this vulnerable group of patients. It might mean that they are at more serious risk than others,” Abraham said.
People with suppressed immune systems, such as those undergoing chemotherapy or suffering from HIV are more likely to fall ill from infections.
The Great Swine Flu Cover Up
November 20, 2009
Foreign Policy
By Alan I. Sipress
As swine flu was spreading around the globe this spring, a senior disease specialist from the World Health Organization (WHO) held an urgent conference call with top British health officials. In the conversation this May, later described as “aggressive” by sources familiar with the discussion, the WHO official accused the British of concealing the extent of their country’s swine-flu outbreak. Among those with swine-flu symptoms, Britain was only counting people who had traveled to places that, like Mexico, had already confirmed an outbreak of the virus, known to scientists as H1N1. Their method left much to be desired in a country where the virus was already spreading fast. Countless Britons fell sick and were intentionally left uncounted.
More… Governments, of course, have a long history of concealing outbreaks, and this year’s flu pandemic, while the first of this particular century, was certainly not the first to be brushed under the rug. The consequences of cloaking swine flu weren’t disastrous on this occasion, but the result will not always be so benign. In fact, at this very moment, another virus — with the potential to be far more devastating — is continuing to seed infections, frustrating efforts to root it out. That virus, H5N1, or avian flu, is a far more lethal strain. And you guessed it: front-line countries’ records in candidly reporting the disease’s spread don’t bode well.
If there’s one thing past pandemics have taught, it’s that curing the world of flu is impossible unless countries are upfront about their outbreaks. Armed with that vital information, health officials can take steps to slow the spreading infection and, if containment fails, ramp up emergency medical care and other vital services. Without timely disclosures, it’s much harder for virus hunters to discover how an emerging disease attacks its victims and transmits to others; it’s also much tougher to get virus samples for study in the lab.
Given all this, why would governments try to keep down their official infection tallies? Most likely, fear of stigma and all the economic consequences that follow. When the WHO placed its call to London last spring, the agency was still weighing whether to raise its state of alert and declare that the swine flu epidemic was a full-blown pandemic, a dramatic step that would signal all countries to ready themselves for the brunt of the new virus. It was clear that the virus was spreading in the Western Hemisphere, especially in the United States and Mexico. But under the agency’s criteria, a pandemic could be declared only if “community-level outbreaks” were confirmed in more than one region of the world. If Britain acknowledged that the virus was spreading widely, that would add Europe to the list and push the outbreak across the pandemic threshold.
